
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-06ABCL3Initial Statement of Beneficial Ownership of Securities
This filing reports an initial statement of beneficial ownership of securities for Lynn Seely, a director at AbCellera Biologics Inc. The filing, dated June 30, 2026, indicates that Seely has no direct or indirect ownership of securities as of the reporting date. The document was filed by Tryn Stimart, acting as attorn...
Small CapBiotechnology